instrument_fundamentals
| date | Close | change | Change (%) | instr__open | High | Low |
|---|
instr__news
Healthy Returns: FDA may add strongest safety warning to Covid shots
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
FDA intends to put its most serious warning on Covid vaccines, sources say | CNN
RFK Jr.'s Former Group Urges FDA to Revoke COVID Vax Licenses | MedPage Today
Moderna Secures $1.5B Five-Year Loan from Ares Management Ahead of Strategy Update
An Olympic-sized effort: CIOs prep for AI disruption in 2026
FDA investigating possible adult deaths from COVID vaccines - San Diego Union-Tribune
'Misbranded': Petition urges delicensing of COVID shots over failure to comply with rules * WorldNetDaily * by Bob Unruh
First Trust Advisors LP Has $34.02 Million Holdings in Moderna, Inc. $MRNA
Ossiam Has $3.08 Million Stake in Moderna, Inc. $MRNA - Daily Political
Invesco Ltd. Has $195.92 Million Holdings in Moderna, Inc. $MRNA
Lido Advisors LLC Sells 140,814 Shares of Moderna, Inc. $MRNA
How Recent Shifts Are Changing the Narrative for Moderna Stock
58,854 Shares in Moderna, Inc. $MRNA Bought by Quantbot Technologies LP
Moderna, Inc. $MRNA Stake Cut by New York State Common Retirement Fund - Markets Daily
Moderna, Inc. $MRNA Stock Position Lessened by New York State Common Retirement Fund
Moderna (NASDAQ:MRNA) Shares Up 6.3% - Still a Buy?
Traders Purchase Large Volume of Moderna Call Options (NASDAQ:MRNA)
Best Biotech Stocks To Watch Now - December 6th - Daily Political
Novavax, Inc. (NVAX): A Bull Case Theory
Protagonist Therapeutics, Inc. (PTGX): A Bull Case Theory
Why Is Moderna (MRNA) Stock Rocketing Higher Today
Moderna Sees Unusually High Options Volume (NASDAQ:MRNA) - Daily Political
First long-term study on COVID deaths suggests vaccines safe four years on
Should Moderna's (MRNA) New US$1.5 Billion Term Loan Amid Tighter FDA Scrutiny Prompt Investor Action?
CureVac N.V. (CVAC): A Bull Case Theory
Future of Business: Moderna's Founder on Innovation That Breaks Through
Norges Bank Buys Shares of 3,439,999 Moderna, Inc. $MRNA
Moderna, Inc. $MRNA Shares Sold by Hsbc Holdings PLC
Moderna (MRNA): Reassessing Valuation After FDA Signals Tougher Vaccine Approval Standards
Vaccine stocks brace for shock waves at this week's ACIP meeting
Stock Index Futures Gain as Investors Recover Risk Appetite
Vaccine stocks slide as FDA official links COVID vaccines and heart conditions in young men | Morningstar
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men | Morningstar
Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino
Moderna falls after FDA vows to impose new vaccine requirements
Moderna Falls as FDA Vows to Impose New Vaccine Requirements (1)
Cetera Investment Advisers Raises Stake in Moderna, Inc. $MRNA
Moderna, Inc. $MRNA Shares Bought by Charles Schwab Investment Management Inc.
Rhumbline Advisers Acquires 25,390 Shares of Moderna, Inc. $MRNA
Moderna, Inc. $MRNA Shares Sold by Quadrature Capital Ltd - Stock Observer
Moderna, Inc. $MRNA Shares Bought by Virtus Investment Advisers LLC - Markets Daily
A Fresh Look at Moderna (MRNA) Valuation After Strategic Pipeline Cuts and US Manufacturing Shift
Moderna Must Face Northwestern Patent Suit Over Covid Vaccine
Legal & General Group Plc Sells 845,459 Shares of Moderna, Inc. $MRNA
Rockefeller Capital Management L.P. Sells 54,235 Shares of Moderna, Inc. $MRNA
Moderna, Inc. (NASDAQ:MRNA) Receives Average Recommendation of "Reduce" from Analysts
Rockefeller Capital Management L.P. Decreases Stake in Moderna, Inc. $MRNA - Stock Observer
Ensign Peak Advisors Inc Has $3.42 Million Position in Moderna, Inc. $MRNA
Moderna, Inc. $MRNA Shares Sold by Jefferies Financial Group Inc. - Markets Daily
Handelsbanken Fonder AB Sells 62,447 Shares of Moderna, Inc. $MRNA - Markets Daily
Jefferies Financial Group Inc. Sells 109,640 Shares of Moderna, Inc. $MRNA - Stock Observer
Himension Capital Singapore PTE. LTD. Sells 2,290 Shares of Moderna, Inc. $MRNA - Daily Political
Ensign Peak Advisors Inc Buys 29,265 Shares of Moderna, Inc. $MRNA - Stock Observer
Moderna, Inc. $MRNA Shares Sold by Nomura Asset Management Co. Ltd.
Entropy Technologies LP Invests $552,000 in Moderna, Inc. $MRNA
Analysts' Recent Ratings Changes for Moderna (MRNA)
Moderna is the S&P 500's most shorted stock: Here's why
Vanguard Group Inc. Buys 1,312,192 Shares of Moderna, Inc. $MRNA
Creative Planning Increases Stock Holdings in Moderna, Inc. $MRNA
Promising Biotech Stocks To Follow Today - November 23rd - Markets Daily
Universal Beteiligungs und Servicegesellschaft mbH Reduces Position in Moderna, Inc. $MRNA - Markets Daily
Moderna (NASDAQ:MRNA) Reaches New 52-Week Low - Here's What Happened
Royal Bank Of Canada Lowers Moderna (NASDAQ:MRNA) Price Target to $25.00
Moderna (NASDAQ:MRNA) Price Target Lowered to $25.00 at Royal Bank Of Canada - Stock Observer
RFK told CDC to change website language on autism and vaccines, NYT reports | Markets Insider
Leerink Partners Issues Positive Forecast for Moderna (NASDAQ:MRNA) Stock Price - Markets Daily
22,410 Shares in Moderna, Inc. $MRNA Acquired by Catalyst Funds Management Pty Ltd
Moderna (MRNA): Evaluating Valuation After Restructuring, Pipeline Cuts, and New Financing Moves
Moderna (NASDAQ:MRNA) Sets New 12-Month Low - Here's Why - Stock Observer
Non-dilutive financing from premier lender bolsters strong b
Announces three-year business strategy and commercial growth
Moderna takes $1.5 billion loan, expects 10% revenue growth next year
Moderna to complete US mRNA manufacturing network with $140 million investment
Moderna (MRNA) Is Down 6.7% After Lowering 2025 Revenue Outlook and Posting Q3 Loss
Moderna, Inc. $MRNA Stock Position Lifted by Letko Brosseau & Associates Inc.
SG Americas Securities LLC Purchases 487,734 Shares of Moderna, Inc. $MRNA
Moderna, Inc. $MRNA Shares Sold by Aviva PLC | MarketBeat
Letko Brosseau & Associates Inc. Has $25.33 Million Stake in Moderna, Inc. $MRNA - Daily Political
Resona Asset Management Co. Ltd. Reduces Holdings in Moderna, Inc. $MRNA
Moderna (MRNA): Reassessing Valuation After Q3 Earnings Beat and Updated Guidance
Tobam Purchases 55,542 Shares of Moderna, Inc. $MRNA
Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Taiwan News | Nov. 13, 2025 20:30
